Production (Stage)
Ventyx Biosciences, Inc.
VTYX
$1.69
-$0.13-7.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.44M | -29.35M | -35.25M | -31.95M | -38.57M |
| Total Depreciation and Amortization | 356.00K | 315.00K | 309.00K | 316.00K | 408.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.44M | 3.09M | 2.84M | 3.02M | 4.51M |
| Change in Net Operating Assets | -2.07M | 2.70M | -3.36M | 4.07M | -13.97M |
| Cash from Operations | -25.72M | -23.25M | -35.46M | -24.54M | -47.63M |
| Capital Expenditure | -16.00K | -6.00K | 0.00 | -60.00K | -175.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.43M | -10.99M | 29.25M | -75.46M | 41.94M |
| Cash from Investing | 26.42M | -11.00M | 29.25M | -75.52M | 41.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 222.00K | 12.00K | -- | 96.18M |
| Repurchase of Common Stock | -- | -- | -- | -906.00K | -- |
| Issuance of Preferred Stock | -- | -- | 26.85M | -- | -- |
| Repurchase of Preferred Stock | -- | -247.00K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -25.00K | 26.86M | -906.00K | 96.18M |
| Foreign Exchange rate Adjustments | 119.00K | -233.00K | 192.00K | -9.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 816.00K | -34.51M | 20.84M | -100.97M | 90.32M |